• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病。
P T. 2014 Aug;39(8):576-7.
2
Genetic determinants associated with early age of diagnosis of IBD.与炎症性肠病早期诊断相关的遗传决定因素。
Dis Colon Rectum. 2015 Mar;58(3):321-7. doi: 10.1097/DCR.0000000000000274.
3
Redo IPAA After a Failed Pouch In Patients With Crohn's Disease: Is It Worth Trying?克罗恩病患者经肛门内镜微创手术（pouch）失败后再次行经肛门内镜微创手术（IPAA）：是否值得一试？
Dis Colon Rectum. 2020 Jun;63(6):823-830. doi: 10.1097/DCR.0000000000001644.
4
Inflammatory bowel disease. Part II: Clinical and therapeutic aspects.炎症性肠病。第二部分：临床与治疗方面。
Dis Mon. 1991 Nov;37(11):669-746. doi: 10.1016/s0011-5029(05)80013-6.
5
Inflammatory bowel disease. Part I: Nature and pathogenesis.炎症性肠病。第一部分：性质与发病机制。
Dis Mon. 1991 Oct;37(10):605-66. doi: 10.1016/0011-5029(91)90024-6.
6
Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?克罗恩病与溃疡性结肠炎中RANTES表达的比较：对鉴别诊断有帮助吗？
J Clin Pathol. 2006 Oct;59(10):1066-72. doi: 10.1136/jcp.2005.034983. Epub 2006 Mar 24.
7
Clinical features of ulcerative colitis and Crohn's disease in Turkey.土耳其溃疡性结肠炎和克罗恩病的临床特征。
J Gastrointestin Liver Dis. 2009 Jun;18(2):157-62.
8
Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.瑞士炎症性肠病相关住院前 12 个月治疗模式和医疗保健使用的系统分析。
Eur J Gastroenterol Hepatol. 2020 Mar;32(3):350-357. doi: 10.1097/MEG.0000000000001616.
9
Diagnostic problems and advances in inflammatory bowel disease.炎症性肠病的诊断问题与进展
Mod Pathol. 2003 Apr;16(4):347-58. doi: 10.1097/01.MP.0000064746.82024.D1.
10
Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population.土耳其人群中克罗恩病和溃疡性结肠炎的IL23R、JAK2及STAT3基因多态性与基因-基因相互作用的研究
Turk J Gastroenterol. 2016 Nov;27(6):525-536. doi: 10.5152/tjg.2016.16327.

引用本文的文献

1
DCLK1 isoform (DCLK1-S) as a critical player in promoting inflammation, tissue remodeling, and EMT in mouse models of colitis.DCLK1 异构体（DCLK1-S）在促进结肠炎小鼠模型中的炎症、组织重塑和上皮-间质转化过程中起关键作用。
PLoS Pathog. 2025 Aug 21;21(8):e1013360. doi: 10.1371/journal.ppat.1013360. eCollection 2025 Aug.
2
Nutritional Habits in Crohn's Disease Onset and Management.克罗恩病发病与管理中的营养习惯
Nutrients. 2025 Jan 31;17(3):559. doi: 10.3390/nu17030559.
3
The effects of dairy on the gut microbiome and symptoms in gastrointestinal disease cohorts: a systematic review.乳制品对胃肠道疾病队列中肠道微生物群及症状的影响：一项系统综述
Gut Microbiome (Camb). 2024 May 7;5:e5. doi: 10.1017/gmb.2024.2. eCollection 2024.
4
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease.中重度活动期克罗恩病患者克罗恩症状严重程度（CSS）问卷的内容效度和心理测量学评价。
Adv Ther. 2024 Sep;41(9):3678-3705. doi: 10.1007/s12325-024-02923-9. Epub 2024 Aug 6.
5
Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches.炎症性肠病治疗方法与肠道微生物群之间的相互作用揭示了新型治疗方法的机会。
Microbiome Res Rep. 2023 Sep 26;2(4):35. doi: 10.20517/mrr.2023.41.
6
Mucosal Metabolomic Signatures in Chronic Colitis: Novel Insights into the Pathophysiology of Inflammatory Bowel Disease.慢性结肠炎中的黏膜代谢组学特征：对炎症性肠病病理生理学的新见解
Metabolites. 2023 Jul 23;13(7):873. doi: 10.3390/metabo13070873.
7
graph-GPA 2.0: improving multi-disease genetic analysis with integration of functional annotation data.Graph-GPA 2.0：通过整合功能注释数据改进多疾病遗传分析
Front Genet. 2023 Jul 12;14:1079198. doi: 10.3389/fgene.2023.1079198. eCollection 2023.
8
Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) in Patients with Crohn's Disease and Ulcerative Colitis.克罗恩病和溃疡性结肠炎患者慢性疾病治疗功能评估-疲劳量表（FACIT-疲劳量表）的内容效度和心理测量学评价
Pharmacoecon Open. 2023 Sep;7(5):823-840. doi: 10.1007/s41669-023-00419-w. Epub 2023 Jun 9.
9
Health Status, Quality of Life, Psychosocial Well-being, and Wearables Data of Patients With Active Ulcerative Colitis Receiving Filgotinib Therapy (FilgoColitis Study): Protocol for a Real-world Observational Study.接受非戈替尼治疗的活动性溃疡性结肠炎患者的健康状况、生活质量、心理社会幸福感及可穿戴设备数据（非戈替尼治疗溃疡性结肠炎研究）：一项真实世界观察性研究方案
JMIR Res Protoc. 2023 May 8;12:e42574. doi: 10.2196/42574.
10
The protective effect of IL-12/23 neutralizing antibody in sarcopenia associated with dextran sulfate sodium-induced experimental colitis.白细胞介素-12/23 中和抗体对葡聚糖硫酸钠诱导的实验性结肠炎相关的肌肉减少症的保护作用。
J Cachexia Sarcopenia Muscle. 2023 Apr;14(2):1096-1106. doi: 10.1002/jcsm.13208. Epub 2023 Mar 5.

溃疡性结肠炎和克罗恩病。

Ulcerative colitis and Crohn's disease.

作者信息

Gohil Kunj, Carramusa Brielle

出版信息

P T. 2014 Aug;39(8):576-7.

PMID:25136256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4123809/
Abstract

As new drugs emerge from the pipeline for the nearly 2 billion patients globally diagnosed with ulcerative colitis and Crohn's disease, sales of therapies for these conditions are expected to increase from $7.35 billion today to $11.05 billion in 2022.

摘要

随着针对全球近20亿被诊断患有溃疡性结肠炎和克罗恩病的患者的新药不断推出，这些病症的治疗药物销售额预计将从目前的73.5亿美元增长到2022年的110.5亿美元。